ABBV vs. LLY
Compare and contrast key facts about AbbVie Inc. (ABBV) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABBV or LLY.
Correlation
The correlation between ABBV and LLY is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABBV vs. LLY - Performance Comparison
Loading data...
Key characteristics
ABBV:
0.82
LLY:
0.00
ABBV:
1.18
LLY:
0.20
ABBV:
1.18
LLY:
1.03
ABBV:
1.10
LLY:
-0.08
ABBV:
2.67
LLY:
-0.15
ABBV:
8.52%
LLY:
12.52%
ABBV:
27.67%
LLY:
38.16%
ABBV:
-45.09%
LLY:
-68.27%
ABBV:
-11.46%
LLY:
-21.03%
Fundamentals
ABBV:
$326.55B
LLY:
$659.45B
ABBV:
$2.34
LLY:
$12.27
ABBV:
78.89
LLY:
59.87
ABBV:
0.39
LLY:
1.16
ABBV:
5.69
LLY:
13.46
ABBV:
229.63
LLY:
44.23
ABBV:
$57.37B
LLY:
$49.00B
ABBV:
$44.44B
LLY:
$40.03B
ABBV:
$16.33B
LLY:
$16.67B
Returns By Period
In the year-to-date period, ABBV achieves a 8.97% return, which is significantly higher than LLY's -1.96% return. Over the past 10 years, ABBV has underperformed LLY with an annualized return of 15.94%, while LLY has yielded a comparatively higher 28.72% annualized return.
ABBV
8.97%
9.58%
11.01%
22.54%
21.38%
15.94%
LLY
-1.96%
3.16%
-8.93%
0.06%
38.62%
28.72%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABBV vs. LLY — Risk-Adjusted Performance Rank
ABBV
LLY
ABBV vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ABBV vs. LLY - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.36%, more than LLY's 0.71% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.36% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
LLY Eli Lilly and Company | 0.71% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
ABBV vs. LLY - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for ABBV and LLY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ABBV vs. LLY - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 9.61%, while Eli Lilly and Company (LLY) has a volatility of 21.88%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ABBV vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. LLY - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.